Literature DB >> 17146712

Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Leo Beletsky1, Robin Ruthazer, Grace E Macalino, Josiah D Rich, Litjen Tan, Scott Burris.   

Abstract

Naloxone, the standard treatment for heroin overdose, is a safe and effective prescription drug commonly administered by emergency room physicians or first responders acting under standing orders of physicians. High rates of overdose deaths and widely accepted evidence that witnesses of heroin overdose are often unwilling or unable to call 9-1-1 has led to interventions in several US cities and abroad in which drug users are instructed in overdose rescue techniques and provided a "take-home" dose of naloxone. Under current Food and Drug Administration (FDA) regulations, such interventions require physician involvement. As part of a larger study to evaluate the knowledge and attitudes of doctors towards providing drug treatment and harm reduction services to injection drug users (IDUs), we investigated physician knowledge and willingness to prescribe naloxone. Less than one in four of the respondents in our sample reported having heard of naloxone prescription as an intervention to prevent opiate overdose, and the majority reported that they would never consider prescribing the agent and explaining its application to a patient. Factors predicting a favorable attitude towards prescribing naloxone included fewer negative perceptions of IDUs, assigning less importance to peer and community pressure not to treat IDUs, and increased confidence in ability to provide meaningful treatment to IDUs. Our data suggest that steps to promote naloxone distribution programs should include physician education about evidence-based harm minimization schemes, broader support for such initiatives by professional organizations, and policy reform to alleviate medicolegal concerns associated with naloxone prescription. FDA re-classification of naloxone for over-the-counter sales and promotion of nasal-delivery mechanism for this agent should be explored.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17146712      PMCID: PMC2078257          DOI: 10.1007/s11524-006-9120-z

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  38 in total

1.  Alcohol, drugs and stigma.

Authors:  E B Ritson
Journal:  Int J Clin Pract       Date:  1999 Oct-Nov       Impact factor: 2.503

2.  Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.

Authors:  M Weinrich; M Stuart
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

3.  A survey of pessary use by members of the American urogynecologic society.

Authors:  G W Cundiff; A C Weidner; A G Visco; R C Bump; W A Addison
Journal:  Obstet Gynecol       Date:  2000-06       Impact factor: 7.661

4.  Analgesic administration to patients with an acute abdomen: a survey of emergency medicine physicians.

Authors:  J M Wolfe; D Y Lein; K Lenkoski; H A Smithline
Journal:  Am J Emerg Med       Date:  2000-05       Impact factor: 2.469

5.  Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.

Authors:  J Strang; B Powis; D Best; L Vingoe; P Griffiths; C Taylor; S Welch; M Gossop
Journal:  Addiction       Date:  1999-02       Impact factor: 6.526

6.  Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users.

Authors:  Lin Ding; Bruce E Landon; Ira B Wilson; Mitchell D Wong; Martin F Shapiro; Paul D Cleary
Journal:  Arch Intern Med       Date:  2005-03-28

Review 7.  Acute heroin overdose.

Authors:  K A Sporer
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

8.  Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians.

Authors:  Phillip O Coffin; Shannon Blaney; Crystal Fuller; Liza Vadnai; Sarah Miller; David Vlahov
Journal:  Am J Drug Alcohol Abuse       Date:  2006       Impact factor: 3.829

9.  Attitudes of Emergency Medical Service providers towards naloxone distribution programs.

Authors:  Karin E Tobin; Wade R Gaasch; Carla Clarke; Ellen MacKenzie; Carl A Latkin
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

10.  Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.

Authors:  Karen H Seal; Robert Thawley; Lauren Gee; Joshua Bamberger; Alex H Kral; Dan Ciccarone; Moher Downing; Brian R Edlin
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

View more
  31 in total

1.  Law enforcement attitudes toward overdose prevention and response.

Authors:  Traci C Green; Nickolas Zaller; Wilson R Palacios; Sarah E Bowman; Madeline Ray; Robert Heimer; Patricia Case
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

2.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

3.  Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Authors:  Ingrid A Binswanger; Stephen Koester; Shane R Mueller; Edward M Gardner; Kristin Goddard; Jason M Glanz
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

4.  Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.

Authors:  Karla D Wagner; Lin Liu; Peter J Davidson; Jazmine Cuevas-Mota; Richard F Armenta; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

5.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

6.  Prevention of fatal opioid overdose.

Authors:  Leo Beletsky; Josiah D Rich; Alexander Y Walley
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

7.  Reducing opioid overdose in Kazakhstan: A randomized controlled trial of a couple-based integrated HIV/HCV and overdose prevention intervention "Renaissance".

Authors:  Louisa Gilbert; Timothy Hunt; Sholpan Primbetova; Assel Terlikbayeva; Mingway Chang; Elwin Wu; Tara McCrimmon; Nabila El-Bassel
Journal:  Int J Drug Policy       Date:  2018-02-08

8.  The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program.

Authors:  Hyunjee Kim; Daniel M Hartung; Reside L Jacob; Dennis McCarty; K John McConnell
Journal:  Psychiatr Serv       Date:  2016-01-14       Impact factor: 3.084

9.  Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality.

Authors:  Daniel Kim; Kevin S Irwin; Kaveh Khoshnood
Journal:  Am J Public Health       Date:  2009-01-15       Impact factor: 9.308

Review 10.  2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

Authors:  R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.